141 related articles for article (PubMed ID: 25317799)
1. Group IIa secretory phospholipase A2 (sPLA2IIa) and progression in patients with lung cancer.
Wang M; Hao FY; Wang JG; Xiao W
Eur Rev Med Pharmacol Sci; 2014; 18(18):2648-54. PubMed ID: 25317799
[TBL] [Abstract][Full Text] [Related]
2. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells.
Dong Z; Meller J; Succop P; Wang J; Wikenheiser-Brokamp K; Starnes S; Lu S
Int J Oncol; 2014 Sep; 45(3):978-84. PubMed ID: 24913497
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
[TBL] [Abstract][Full Text] [Related]
4. Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.
Jiang J; Neubauer BL; Graff JR; Chedid M; Thomas JE; Roehm NW; Zhang S; Eckert GJ; Koch MO; Eble JN; Cheng L
Am J Pathol; 2002 Feb; 160(2):667-71. PubMed ID: 11839587
[TBL] [Abstract][Full Text] [Related]
5. Plasma secretory phospholipase A2-IIa as a potential biomarker for lung cancer in patients with solitary pulmonary nodules.
Kupert E; Anderson M; Liu Y; Succop P; Levin L; Wang J; Wikenheiser-brokamp K; Chen P; Pinney SM; Macdonald T; Dong Z; Starnes S; Lu S
BMC Cancer; 2011 Dec; 11():513. PubMed ID: 22151235
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of secretory phospholipase A2 IIa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma.
Halpern AL; Kohtz PD; Rove JY; Ao L; Meng X; Fullerton DA; Weyant MJ
Mol Cell Biochem; 2019 Jun; 456(1-2):145-156. PubMed ID: 30684134
[TBL] [Abstract][Full Text] [Related]
7. Expression of Secretory Phospholipase A2 Group IIa in Breast Cancer and Correlation to Prognosis in a Cohort of Advanced Breast Cancer Patients.
Jespersen SS; Stovgaard ES; Nielsen D; Christensen TD; Buhl ASK; Christensen IJ; Balslev E
Appl Immunohistochem Mol Morphol; 2021 Jan; 29(1):e5-e9. PubMed ID: 32217848
[TBL] [Abstract][Full Text] [Related]
8. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cell phenotype is supported by secretory phospholipase A2 in human lung cancer cells.
Bennett DT; Deng XS; Yu JA; Bell MT; Mauchley DC; Meng X; Reece TB; Fullerton DA; Weyant MJ
Ann Thorac Surg; 2014 Aug; 98(2):439-45; discussion 445-6. PubMed ID: 24928671
[TBL] [Abstract][Full Text] [Related]
10. Secretory Phospholipase A2 IIa Mediates Expression of Growth Factor Receptors in Esophageal Adenocarcinoma.
Halpern AL; Kohtz PD; White AM; Houk AK; Rehring JF; Hanson L; McCarter MD; Joshi M; Meng X; Fullerton DA; Weyant MJ
Dig Dis Sci; 2021 Mar; 66(3):784-795. PubMed ID: 32277371
[TBL] [Abstract][Full Text] [Related]
11. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.
Oleksowicz L; Liu Y; Bracken RB; Gaitonde K; Burke B; Succop P; Levin L; Dong Z; Lu S
Prostate; 2012 Jul; 72(10):1140-9. PubMed ID: 22127954
[TBL] [Abstract][Full Text] [Related]
12. Transcription repressor slug promotes carcinoma invasion and predicts outcome of patients with lung adenocarcinoma.
Shih JY; Tsai MF; Chang TH; Chang YL; Yuan A; Yu CJ; Lin SB; Liou GY; Lee ML; Chen JJ; Hong TM; Yang SC; Su JL; Lee YC; Yang PC
Clin Cancer Res; 2005 Nov; 11(22):8070-8. PubMed ID: 16299238
[TBL] [Abstract][Full Text] [Related]
13. Vav3 oncogene is involved in regulation of secretory phospholipase A2-IIa expression in prostate cancer.
Dong Z; Liu Y; Levin L; Oleksowicz L; Wang J; Lu S
Oncol Rep; 2011 Jun; 25(6):1511-6. PubMed ID: 21455584
[TBL] [Abstract][Full Text] [Related]
14. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.
Lagorce-Pagès C; Paraf F; Wendum D; Martin A; Fléjou JF
Virchows Arch; 2004 May; 444(5):426-35. PubMed ID: 15045585
[TBL] [Abstract][Full Text] [Related]
15. Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade.
Graff JR; Konicek BW; Deddens JA; Chedid M; Hurst BM; Colligan B; Neubauer BL; Carter HW; Carter JH
Clin Cancer Res; 2001 Dec; 7(12):3857-61. PubMed ID: 11751475
[TBL] [Abstract][Full Text] [Related]
16. Increased expression and activity of group IIA and X secretory phospholipase A2 in peritumoral versus central colon carcinoma tissue.
Tribler L; Jensen LT; Jørgensen K; Brünner N; Gelb MH; Nielsen HJ; Jensen SS
Anticancer Res; 2007; 27(5A):3179-85. PubMed ID: 17970059
[TBL] [Abstract][Full Text] [Related]
17. Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth.
Belinsky GS; Rajan TV; Saria EA; Giardina C; Rosenberg DW
Mol Carcinog; 2007 Feb; 46(2):106-16. PubMed ID: 17091473
[TBL] [Abstract][Full Text] [Related]
18. Context-dependent effect of sPLA
Chovatiya GL; Sunkara RR; Roy S; Godbole SR; Waghmare SK
EBioMedicine; 2019 Oct; 48():364-376. PubMed ID: 31521610
[TBL] [Abstract][Full Text] [Related]
19. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
Masuda S; Murakami M; Ishikawa Y; Ishii T; Kudo I
Biochim Biophys Acta; 2005 Oct; 1736(3):200-10. PubMed ID: 16188494
[TBL] [Abstract][Full Text] [Related]
20. Secretory phospholipase A
Chovatiya GL; Sarate RM; Sunkara RR; Gawas NP; Kala V; Waghmare SK
Sci Rep; 2017 Sep; 7(1):11619. PubMed ID: 28912581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
